Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.

Gossmann, Jan

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. [electronic resource] - Transplant international : official journal of the European Society for Organ Transplantation Jun 2007 - 558-62 p. digital

Publication Type: Case Reports; Journal Article

0934-0874

10.1111/j.1432-2277.2007.00477.x doi


Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Biopsy
Female
Glomerulosclerosis, Focal Segmental--drug therapy
Humans
Immunologic Factors--therapeutic use
Kidney Failure, Chronic--etiology
Kidney Transplantation--adverse effects
Middle Aged
Nephrotic Syndrome--complications
Proteinuria--drug therapy
Recurrence
Renal Dialysis
Reoperation
Rituximab
Treatment Outcome